Loading data for INDP — first visit, this takes a few seconds.
Indaptus Therapeutics Inc... (INDP)
NasdaqCM: INDP
· Echtzeitkurs · USD
1.07
+0.01 (0.94%)
Zum Schluss: Aug 19, 2026, 3:57 PM
0.94
+0.00%
Nachbörslich: 4:00 PM
Indaptus Therapeutics Inc. (INDP) Stock Price, Analysis & Data
0.94% (1D)
| Geld | 0.78 |
| Marktkapitalisierung | 125.25 Mio |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | -15.42 Mio |
| Beta | n/a |
| EPS (ttm) | -3.56 |
| KGV (TTM) | n/a |
| Forward-KGV | -0.68 |
| KBV (TTM) | 85.45 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | 1.34 |
| Volumen | 130,789 |
| Ø Vol. (20D) | 1,032,104 |
| Eröffnung | 1.09 |
| Vortagesschluss | 1.06 |
| Tagesspanne | 1.02 - 1.15 |
| 52-Wk Range | 0.92 - 8.57 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über INDP
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as f...
Branche Biotechnology
Sektor Healthcare
IPO Datum Aug 4, 2015
Mitarbeiter 5
Börse NasdaqCM
Tickersymbol INDP
Website https://indaptusrx.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Indaptus Therapeutics 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -20.85 Mio, ein Anstieg von 38.79 %.
FinanzberichteGewinnüberraschung
Indaptus Therapeutics hat die Quartalszahlen am Mar 17, 2026 veröffentlicht: